2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$4.75+$0.005 (+0.11%)
Price as of Aug 03, 2026 10:21 AM EDT- $337.4MMarket Cap
- 253.73%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$4.75+$0.005 (+0.11%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.74 | ||
Change | -$0.18 (-3.66%) | ||
Open | $4.95 | ||
High | $4.99 | ||
Low | $4.66 | ||
Previous Close | $4.92 | ||
Volume | 941,181 | ||
30-Day Average Volume | 1,190,641 | ||
1-Week Change | 9.47% | ||
1-Month Change | -2.27% | ||
1-Year Change | 253.73% | ||
3-Year Change | -82.25% | ||
5-Year Change | -91.09% | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $253.1M | ||
Market Cap | $337.4M | ||
Enterprise Value | $305.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.4M | ||
Free Cash Flow | -$33.0M | ||
EBIT | -$35.2M | ||
EBITDA | -$35.1M | ||
Net Working Capital | $182.9M | ||
EPS | -$0.50 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -9 | ||
PEG | 5 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue